OBTAINING YOUR CE STATEMENT OF CREDIT

Objectives

The 49^th ICAAC scientific program offers an educational forum which:

• Disseminates new data from research of basic microbiological sciences related to human disease;
• Updates medical professionals on clinical diagnoses, preventative modalities and therapeutics;
• Investigates the pathogenesis and epidemiology of old and new microbes;
• Evaluates the spread of infectious diseases throughout the world;
• Analyzes the developing resistance of pathogens to divers therapeutics;
• Introduces new antimicrobial agents; and
• Considers the most recent trends in healthcare management.
  

Intended Audience
The 49^th ICAAC is designed to meet the needs of health-care professionals, particularly physicians, clinical microbiologists, researchers and pharmacists, specializing in infectious diseases. Current trends will be covered regarding:

• Antimicrobial Resistance
• Bioterrorism
• Clinical Trials
• Community-Acquired Infections
• Epidemiology
• HIV/AIDS and other Retroviruses
• Laboratory Diagnostics
• Microbial Pathogenesis
• Mycology
• New Drugs
• Nosocomial Infections
• Parasitology
• Pharmacology
• Susceptibility Studies
• Vaccines and Immunology
• Virology

49^th ICAAC Continuing Education (CE)
The following 49^th ICAAC sessions will offer continuing education credit as noted in the Final Program. The Pre conference Workshops will offer additional CE opportunities

Physicians and Microbiologists

Continuing Medical Education
The American Society for Microbiology (ASM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American Society for Microbiology takes responsibility for the content, quality, and scientific integrity of this CME activity.

The ASM designates this educational activity for a maximum of 29.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their level of participation in the activity.

The American Medical Association (AMA) has determined that physicians not licensed in the U.S. who participate in this CME activity are eligible for AMA PRA Category 1 Credits™.

Diplomates of the American Board of Medical Microbiology, Diplomates of the American Board of Medical Laboratory Immunology, and Registrants of the National Registry of Microbiologists may earn AMA PRA Category 1 Credits™ toward re-certification. Each professional should claim credit commensurate with their level of participation in the activity.

Pharmacists
The American Society for Microbiology is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. ASM will award continuing pharmacy education (CPE) credit for participation in select 49^th ICAAC sessions. Current sessions already approved for (CPE) credit will have a corresponding Universal Program Number next to the session title.  Statements of Credit will indicate credits based on participation. ASM complies with the ACPE Accreditation Standards for Continuing Pharmacy Education.

OBTAINING YOUR CE STATEMENT OF CREDIT

California Clinical Laboratory Scientists (CLS)
ASM is accredited by the California Department of Health Services to offer continuing education for California Clinical Laboratory Scientists. All sessions designated for CME credits will also qualify for California CE credits toward CLS license renewal.

Florida Clinical Laboratory Personnel
ASM is accredited by the Florida Department of Health to offer continuing education for Florida Clinical Laboratory Personnel. Those sessions that offer Florida CE contact hours are indicated with the Florida logo in this Final Program.

Other CE Licenses
A Participation Statement of Credit can be obtained by completing the activity evaluation. This is a detailed statement that documents your participation in this activity.

A Statement of Credit may be obtained through the ASM CE Portal. Instructions and links to this site may be found here.

Education Disclaimer
The primary purpose of the sessions at the 49^th ICAAC is education. Information presented, as well as publications, technologies, products, and/or services discussed, are intended to inform you about the knowledge, techniques, and experiences of professionals who are willing to share such information with colleagues. A diversity of professional opinions exists in the fields discussed at ICAAC and the views of the ICAAC faculty are offered solely for educational purposes. Faculty’s views neither represent those of ASM nor constitute endorsement by the association. The ASM disclaims any and all liabilities for damages to any individual attending ICAAC and for all claims which may result from the use of this information, publications, technologies, products, and/or services at ICAAC.

Disclosure Statement
As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), the ASM requires that all faculty members participating in continuing education activities sponsored by ASM disclose any relevant financial relationships related to the content of their presentation(s), as well as any off-label uses of a drug. The ASM then takes steps to resolve any identified conflict of interest. A listing of faculty disclosures is available in the Preliminary Program and online in the Online Program Planner. This policy is intended to make you aware of faculty disclosure so you may form your own judgments about material discussed during the 49^th ICAAC.

If you have concerns (e.g., commercially-biased presentations, promotional materials distributed by presenters and/or participants, etc), please visit the ICAAC Headquarters Office and ask to speak to an ASM staff person so that ASM can respond immediately to your concerns.